MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

During remission, new symptoms typically resolve or improve. MS is a chronic, progressive condition of the central nervous system (CNS) in which your immune system attacks myelin, the protective ...

However, benign MS may change to a progressive form of MS. Multiple sclerosis (MS) can vary greatly from person to person. Benign MS is a term sometimes used to describe a form of MS in which a ...

"This two-stage model is incorrect," he pointed out. "What we call secondary progressive MS is very likely the same process that occurs once relapsing activity is suppressed by highly effective ...

Many people who receive an initial diagnosis of relapsing-remitting MS gradually worsen over time, separate from ...

Background Treatment options for patients suffering from progressive forms of multiple sclerosis (MS) remain inadequate. Mast cells actively participate in the pathogenesis of MS, in part because ...

Rese-cel, previously called CABA-201, is a CAR T-cell therapy that's designed to treat MS by depleting B-cells.

In its first draft guidance, NICE said that Ocrevus (ocrelizumab) is not cost-effective in primary progressive multiple sclerosis (PPMS). The cost-effectiveness body noted clinical trial evidence ...

Switching therapies is a common part of multiple sclerosis management and may be considered for several reasons.

Designation is based on positive results from the HERCULES study in adults with non-relapsing secondary progressive multiple sclerosis (nrSPMS) Tolebrutinib is the first and only brain-penetrant ...

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...